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The histological manifestation of growth-regulating and differentiation-inducing signals in cancer cells is considered as a key
component for clinical outcome prediction and commonly deﬁned as tumor differentiation grade. However, the molecular and
functional framework underlying this clinical parameter remains poorly understood. Our correlative data display a signiﬁcant
association (P40.001) between mitochondrial uncoupling protein 2 (UCP2) and tumor grade in primary breast cancer (n¼234).
Through mechanistic analyses,weshow a synergisticlink between UCP2and established cellular pathwaysinconferring grade-
associated functional phenotypes. Here, the application of well to moderately differentiated primary tumor cell lines has enabled
direct observation of SMAD recruitment to the UCP2 promoter underlying repression of gene transcription. In contrast, poorly
differentiated tumor cells, known to be TGFb resistant, displayed aberrant UCP2 regulation, and consequently, gene
overexpression, which reduced mitochondrial calcium and facilitated the maintenance of mitochondrial membrane potential,
therebysigniﬁcantlydecreasingoxidativestressandinhibitingcelldeath.Conversely,UCP2silencinginsuchcellsrapidlyledto
the induction of apoptosis and cell differentiation, concurrent with reduced cell survival and proliferation, conﬁrming gene-
speciﬁc effects. Demonstration of a biologically driven role for UCP2 dysregulation in promoting multiple characteristics of
tumor aggressiveness strongly endorses assessment of gene expression at clinical presentation to augment therapeutic
decision-making and improve patient outcome through personalized targeting approaches.
Cell Death and Disease (2010) 1, e53; doi:10.1038/cddis.2010.30; published online 15 July 2010
Subject Category: Cancer
The uncoupling protein (UCP) family, currently comprised of
ﬁve members located in the inner mitochondrial membrane,
1
derives its designation from its involvement in uncoupling
oxidative phosphorylation and facilitating energy dissipation
as heat.
2–4 Reports regarding UCP2 expression during
tumorigenesis and chemotherapeutic resistance are just
beginningtoemerge.
5–7Widelyknownasanegativeregulator
of mitochondrial reactive oxygen species (ROS) and mito-
chondria-mediated cell death,
8–11 UCP2 function seems to
be tissue speciﬁc (reviewed in Mattiasson and Sullivan
12).
The detection of UCP2 overexpression in malignancy is
presently limited to the colon.
5 Although no direct evidence
existsfor its role in cancer progression, it seems plausible that
UCP2 assists in the adaptation and survival of tumor cells in
an increasingly hostile tissue microenvironment. The impair-
ment of myogenic differentiation induced by increased UCP2
levels
13 also suggests its contribution to cellular dedifferen-
tiation during tumor evolution. Despite known physiological
functions of UCP2, key regulatory pathways associated
with its expression in human health and disease remain
unidentiﬁed.
Unlike colon, breast cancer is characteristically diverse in
its histological, molecular and clinical phenotype offering
opportunities for improved disease stratiﬁcation. In this
regard, microscopically determined histological grade/differ-
entiation status has long served an important role. On the
basis of a histological evaluation of cell proliferation and
differentiation, evident in tumor cross sections, primary
tumors are assigned low (grade 1 or well differentiated),
intermediate (grade 2 or moderately differentiated) or high
(grade 3 or poorly differentiated) histological grade.
14 Grade 1
tumors are known to confer a relatively good clinical
prognosis, whereas a signiﬁcant proportion of grade 2 and 3
tumors lead to poor patient outcome.
15 More recent efforts
toward reducing the subjectivity associated with microscopic
grade determination through global expression proﬁling of
tumor tissue have greatly improved the predictive accuracy of
intermediate-grade tumors, and conﬁrmed differential activa-
tion of cell cycle and proliferation-related genes (reviewed in
Wirapati et al.
16).
Our experimental design given here has assisted in
revealing a previously unappreciated distinction in the UCP2
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www.nature.com/cddisproﬁles of primary breast cancer of varying histological
grades, providing novel insights regarding the biological
underpinnings of tumor aggressiveness. We have observed
a signiﬁcant elevation of UCP2 levels in poorly differentiated
breast cancer, implicating a pathophysiological role for its
constitutive activation in such tumors. For a direct test of this
assumption, experimentation with live model systems, which
portray and maintain distinctive molecular proﬁles associated
with histological grade, is a prerequisite. Widely available
immortalized cell lines derived from high-grade primary and
metastatic breast cancer, provide only a partial framework for
this purpose. In conjunction with a unique series of authenti-
cated cell lines derived from breast tumors of varying
grades,
17,18 functional changes associated with UCP2 over-
expression have unveiled critical events, other than cell
proliferation, in the divergence between well and poorly
differentiated primary tumors. Toward deﬁning a molecular
basis for the differentiation status of primary breast cancer,
we provide direct evidence for the crosstalk between UCP2
and the TGFb pathway through repressive SMAD binding
elements (RSBEs), which trigger gene repression.
19 Our data
show that intact TGFb/SMAD-dependent signaling tightly
regulates UCP2 expression to maintain a relatively normal-
appearing, well-differentiated epithelial phenotype. In
contrast, in TGFb-resistant high-grade tumors, potentiation
of UCP2 repression fails to occur, contributing to impaired cell
differentiation. Together, such aberrations confer a striking
selective advantage on the one hand by alleviating oxidative
stress-mediated cellular damage and on the other byenabling
cancer cells to surmount Ca
2þ-mediated growth-suppressive
differentiation and death-inducing signals, thereby tipping the
balance toward a higher proliferation index.
Results
Differential expression of UCP2 in primary breast cancer
of varying histological grades. Immunolocalization of anti-
UCP2 antibody on 234 primary breast tumor tissue cores
showed strong mitochondrial staining in the majority of
moderate and poorly differentiated tumors (grades 2 and 3,
respectively). Minimal to no immunostaining was observed
in over 60% well-differentiated (grade 1) tumors (Table 1).
Tissue array-based UCP2 expression (Figure 1a) was
veriﬁed in full-sized tumor sections, wherever available.
Spot checking of UCP2-negative tumors for an independent
gene product, ITGA6, conﬁrmed overall tissue integrity
(data not shown).
Oncomparinggenomicexpressionproﬁlingdata
18between
16novelcelllinesofvaryinggradedevelopedinourlaboratory
and 51 breast epithelial cell lines established by others, unlike
UCP2, all other UCP family members were not differentially
expressed in high versus low/intermediate-grade cell lines.
UCP2 was consistently overexpressed in grade 3 cell lines,
whereas minimal to no expression was observed in grade 1
and some grade 2 lines. A representative subset of four grade
3 and four grade 1 and 2 primary breast cancer cell lines was
used for further phenotypic and functional studies. Grade-
associated differential expression of UCP2 transcripts was
conﬁrmed by two independent quantitative real-time PCR
(QPCR) approaches (Figure 1b), wherein cancer cell expres-
sion was normalized to that of reduction mammoplasty-
derived nonmalignant primary breast epithelial cell cultures.
Differential UCP2 expression was maintained at the protein
level in cell lysates (Figure 1b), as well as in cell-by-cell
microscopic analysis (Figure 1c). Anti-UCP2 and mito-
chondrial-speciﬁc dye, MitoTracker Red, were colocalized in
the mitochondria of tumor cells (Supplementary Figure S1).
The UCP2 overexpression-induced loss of differentiation
was functionally observed as the abrogation of polarity within
multicellular units developed from single cell suspensions in
the three-dimensional growth matrix, Matrigel. Grade 3 tumor
colonies generally formed random, disoriented cell aggre-
gates, denoted as the apolar phenotype (Figure 1d, left
panels), whereas a polarized pattern was characteristically
displayed by colonies of nonmalignant and grade 1 or 2 tumor
cells. UCP2 knockdown (KD) in grade 3 cells resulted in the
restoration of a polarized pattern of colony growth, reﬂected
as basal redistribution of a-6 integrin and acini-like orientation
of nuclei (Figure 1d, right panels). A statistically signiﬁcant
inverse association was observed between UCP2 expression
and polarized growth patterns, characteristic of well-differen-
tiated acinar structures in the mammary gland (Figure 1e).
UCP2 overexpression reﬂects grade-associated TGFb
resistance and altered proliferation and differentiation
signaling. The TGFb exposure inhibited cell proliferation
in grade 1 and 2 cell lines within 24h. Such changes were not
observed in grade 3 cell lines (Figure 2a, left panel). Unlike
the rapid onset of TGFb-induced growth arrest, senescence-
like morphological changes were detected on day 6 of
exposure, but only in grade 1 cells (Figure 2a, right panel).
The TGFb treatment led to further repression of UCP2
transcript levels in grade 1 and 2 but not in multiple grade 3
lines. In addition, expression of TGFb target genes CMYC,
CEACAM6, WNT5B, ESDN, TGFb1R and TGFb2R was
altered, whereas that of four control housekeeping genes
ACTNB, GAPDH, G6PD and ALDOA were unchanged
(Figure 2b). Together, these data provide evidence for
TGFb-mediated UCP2 repression. Furthermore, experimen-
tally introduced UCP2 led to a striking neutralization of TGFb
effects on cell morphology and growth in responsive tumor
cells (Figure 2c).
For further evaluation of UCP2 regulation by TGFb/SMAD,
the 3kb human UCP2 promoter was analyzed by Vector NTI
Suite software (Invitrogen, Carlsbad, CA, USA). Over 20
putative RSBE-like sites were revealed, and 5 regions that
displayed the highest density of such sites are shown
diagrammatically (Figure 2d, top panel). In vivo binding
of SMAD4 (co-SMAD) to these regions was evaluated
in grade 1 cells by chromatin immunoprecipitation (ChIP).
Table 1 UCP2 immunohistochemistry of primary invasive breast cancer
Histologic
grade
Number
of cases
Positive
tumors (%)
Negative
tumors (%)
1 69 25 (36) 44 (64)
2 88 67 (76) 21 (24)
3 77 64 (83) 13 (17)
The proportion of UCP2-positive and negaitive tumors in the grade 1 group is
signiﬁcantly different from grades 2 and 3 (Po0.001)
Role of UCP2 in histological-grade manifestation
A Sayeed et al
2
Cell Death and DiseaseGrade 3 Grade 1
CCdl675
SYBR green
65.2 139.1
508.5
335.5
130.7
0.0
0.1
0.4
275.6
217.8
69.9
0.1
0.1
0.2
FAM probe
CCdl54
CCdl672
CCdl257
CCdl22
CCdl68
CCdl631
600
500
400
300
200
100
0
UCP2(32 KD)
Tubulin(57 KD)
Grade 3 Grade 1 & 2
Grade 3
C
C
d
I
6
7
5
C
C
d
I
5
4
C
C
d
I
6
7
2
C
C
d
I
6
8
C
C
d
I
2
2
C
C
d
I
6
3
1 NS siRNA 75.0
*
*
11.3
25.3
4.3
UCP2
siRNA
polar colony apolar colony
100
70
60
50
40
30
20
10
0
90
80
NS siRNA
C
o
l
o
n
i
e
s
 
p
e
r
 
f
i
e
l
d
UCP2 siRNA
m
e
r
g
e
p
h
a
l
l
o
i
d
i
n
α
 
6
 
i
n
t
e
g
r
i
n
Grade 1 & 2
R
e
l
a
t
i
v
e
 
e
x
p
r
e
s
s
i
o
n
C
C
d
l
6
7
5
C
C
d
l
5
4
C
C
d
l
6
7
2
C
C
d
l
2
5
7
C
C
d
l
2
2
C
C
d
l
6
8
C
C
d
l
6
3
1
Figure 1 UCP2 is differentially expressed by primary breast cancer of varying differentiation status. (a) Distinctive UCP2 expression patterns in four representative cases
each of grade 3 and grade 1 primary breast cancer. Immunoperoxidase signal (blue) in sections of tissue cores (top 3 panels) and full-sized blocks (bottom panels at higher
magniﬁcation, Bar¼25mm). Red, nuclear counter stain. (b) Top – UCP2 transcript levels in primary tumor cell lines of all grades analyzed with QPCR probes labeled with
SYBR Green (open bars), or FAM (solid bars). Bottom – western blot analysis reﬂects variation in UCP2 transcript levels shown above in bar graph. Tubulin, protein-loading
control. (c) UCP2 immunoﬂuorescence (green) in primary breast cancer cell lines evaluated in panel b. Nuclei counterstained with propidium iodide (red). Bar¼25mm.
(d) Cell polarity in Matrigel examined by immunostaining for the basal membrane marker, a6-integrin (blue signal). Actin, a polarity-independent control, was localized with
phalloidin (green). Nuclei were counterstained with propidium iodide. UCP2 knockdown of grade 3 tumor cells (CCdl672) propagated in Matrigel restored polarized growth as
shown in right hand panels. Bar¼25mm. (e) Quantitation of polarity induction by UCP2 knockdown. Apolar structures were deﬁned by random nuclear orientation and
individuala6-integrinencircledcells.Polarizedstructureswerecharacterizedbyredistributionofa6-integrinaroundtheperipheryofanentirecolony.Bargraphrepresentsthe
average of polarized and apolar grade 3 (CCdl672) colonies of control versus UCP2 knockdown cells in Matrigel per  10 ﬁeld in four independent experiments. Asterisks
indicate statistical signiﬁcance (Po0.05)
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Cell Death and DiseaseRobust binding was observed (Figure 2d, bottom panel)
and different regions displayed variable binding efﬁciencies.
Maximum SMAD4 binding was observed in region 5 com-
prised of six putative RSBEs ( 100 to  354) and closest to
the start site. Demonstration of the functional interaction
between SMAD4 and UCP2 in SMAD4 small interfering RNA
(siRNA)-transfected grade 1 and 2 tumor cell lines validated
the ChIP data further. SMAD4-KD cells displayed signiﬁcantly
higher UCP2 transcript levels than control nonspeciﬁc (NS)
siRNA-transfected tumor cells (Figure 2e, left panel). A 50%
SMAD4 reduction was observed in KD cells, accompanied
by increased UCP2 protein levels (Figure 2e, right panel).
OwingtoresidualSMAD4,responsivenesstoTGFbtreatment
seemed to be maintained, although to a much reduced level,
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Cell Death and Diseasevisible as incomplete UCP2 repression (compare bars 2 versus 4,
and3versus4inFigure2e,leftpanel).Together,thesedatashow
thatUCP2transcriptioninducedbySMAD4-KDwasabrogatedby
TGFb treatment, thus conﬁrming its role in SMAD4-mediated
suppression of the UCP2 promoter in cell lines derived from well
and moderately differentiated breast tumors.
Enhancement of mitochondrial membrane potential
(Dwm) by UCP2 is an underlying factor in the inhibition
of apoptotic death in tumor cells. UCP2-KD of grade 3
tumor cells resulted in over 50% reduction in protein levels
(Figure 3a). In such UCP2-silenced cells, carbonyl cyanide
m-chlorophenylhydrazone (CCCP) – a chemical uncoupler –
was remarkably effective in promoting apoptosis as
measured by annexin V (Figure 3a). Owing to this inverse
association with apoptosis induction, we reasoned that UCP2
overexpression might directly inﬂuence Dcm of tumor cells.
Baseline Dcm measured as a ratio of red: green ﬂuores-
cence of the dye JC-1 showed a signiﬁcantly higher Dcmi n
multiple grade 3 cell lines (range 3.1–4.1) compared with
grade 1 and 2 cell lines (range 1.5–2.0) (Supplementary
Figure S2). CCCP-induced dissipation of Dcm was observed
in all tumor lines examined. Notably, UCP2-KD in grade 3
tumorcellsled toa signiﬁcant dropin Dcm(Figure 3b).UCP2-
mediated positive regulation of Dcm was further conﬁrmed by
live cell imaging (Figure 3c). Simultaneously, a direct cell-by-
cell analysis of anti-cleaved caspase-3 immunostaining of
grade 3 UCP2-KD colonies in Matrigel showed a signiﬁcant
increase in spontaneous and staurosporine-induced apopto-
sis (Figure 3d). Together, these ﬁndings support our postulate
that underlying the antiapoptotic function of UCP2 in tumor
cells is its central role in Dcm enhancement. Such UCP2
effects in tumor cells were also evaluated by a reverse
experimentalstrategy,wherebyexogenousUCP2inductionin
grade 1 and 2 cell lines signiﬁcantly alleviated spontaneous
as well as CCCP-mediated mitochondrial depolarization
(Figure 3e), providing unequivocal support for UCP2 as a
positive regulator of Dcm in breast cancer cells.
A comprehensive role for UCP2 overexpression in the
maintenance of the poorly differentiated phenotype of
primary breast cancer. To evaluate additional differential
effects imparted by UCP2 expression in the manifestation of
histological grade, relative endogenous ROS levels were
measured in cell lines of varying grade. Grade 3 cell lines
displayed lower baseline ROS levels than grades 1 and 2
(Supplementary Figure S3). Mean ﬂuorescence intensity
(MFI) measurements of C400 in UCP2-KD variants of these
cell lines displayed a signiﬁcant increase in ROS levels
(2 to 3.5-fold, Figure 4a). Conversely, UCP2 transduction
into grade 1 cells led to further ROS reduction (data not
shown). To ascertain that UCP2-regulated ROS originated
in the mitochondria, a mitochondrial superoxide-speciﬁc
dye, MitoSOX Red, was used in combination with the
MitoTracker, MitoFluor Green. In two independent UCP2-
KD grade 3 lines, a signiﬁcant induction in mitochondrial
superoxide levels was observed microscopically (Figure 4b).
Transfection efﬁciencies 495% were achieved in the
cell lines used (Supplementary Figure S4a). For additional
conﬁrmation of the mitochondrial origin of increased
ROS, live tumor cells were treated with the mitochondrial
complex-3 inhibitor, antimycin A, and superoxide production
was measured at 1min intervals by time-lapse imaging.
As expected, superoxide induction occurred in all cell lines,
regardless of UCP2 status (Supplementary Figure S4b).
Evaluation of mitochondrial superoxide regulation under such
experimental conditions showed that, although baseline
differences between control and UCP2-KD cells were not
evident at the outset, antimycin A treatment signiﬁcantly
enhanced mitochondrial superoxide production in UCP2-KD
cells sampled at 5, 10 and 15min after treatment (Figure 4c).
Such differences for MitoFluor Green were not observed
in the ﬂuorescence-activated cell sorting (FACS) analysis
(data not shown). Supportive evidence for an inverse
association between UCP2 expression and ROS-induced
growth suppression was shown by antioxidant-mediated
alleviation in UCP2-KD grade 3 tumor cells (Figure 4d).
The combined observations strongly support the conclusion
that UCP2 overexpression in grade 3 cell lines negatively
regulates endogenous ROS levels, thereby promoting tumor
cell survival under conditions of microenvironmental stress.
In yet another approach, we examined the association
between UCP2 and basal [Ca
2þ]m (mitochondrial Ca
2þ)
levels in primary breast tumor cell lines of varying histological
grade. The rationale underlying these experiments was that
Figure2 UCP2expressioninbreastcancercellsissuppressedbyTGFbinahistologicalgrade-dependentmanner.(a)TGFbinhibitscellproliferationingrade1and2but
not in grade 3-derived breast cancer cell lines. Left panel – cell proliferation measured by BrdU incorporation and FACS analysis. Averages taken across three independent
experiments. Asterisks indicate statistical signiﬁcance (Po0.05). Right panel – morphological changes induced by TGFb exposure. Dramatic effects are exempliﬁed in a
grade 1 cell line (CCdl68). Such effects were not observed in grade 3 cell lines (CCdl54 shown). (b) Transcript levels of UCP2 and other TGFb target genes were induced or
repressed in TGFb-treated grade 1 and 2 tumor cells only. Data for each test gene were normalized to the reference gene, ACTB. Expression of additional housekeeping
genes, GAPDH, G6PD and ALDOA is also shown. Each data point is the average of triplicate values; error bars denote standard deviation; and asterisks denote Po0.05.
Openbars,notreatmentcontrol;ﬁlledbars,TGFbtreatment.Skyblue,grade1cellline(CCdl68);navyblue,grade2cellline(CCdl78);pink,grade3cellline(CCdl54);purple,
grade 3 cell line (CCdl672). (c) Exogenously induced UCP2 inhibits effects of TGFb on grade 1 and 2 tumor cell lines. UCP2-transfected cells (CCdl66) were analyzed after
5 days of exposure to 4ng/ml TGFb. Representative phase contrast images show UCP2-mediated inhibition of TGFb-induced morphological changes. Bar¼50mm. (d) Top
panel – diagrammatic representation of the human UCP2 promoter showing ﬁve potential RSBE-containing regions and their respective coordinates with respect to the
transcriptionalstartsite.TheﬁguresinparenthesesrepresentthenumberofpotentialRSBEsitesineachregion.Bottompanel–ChIPassayshowsSMAD4bindingtomultiple
regions in the UCP2 promoter in a grade 1 (CCdl68) cell line. Maximum binding was observed in region 5. M, 100 base pair ladder; I, input DNA; C, control IgG
immunoprecipitation; IP, anti-SMAD4 immunoprecipitation. (e) Left panel – TGFb-mediated UCP2 repression is compromised by SMAD4 knockdown. QPCR analysis shows
signiﬁcant alleviation of UCP2 repression in SMAD4 siRNA-transfected cell lines. Open bars – grade 1 cell line (CCdl68); solid bars – grade 2 cell line (CCdl78). Each data
point is the average of triplicate values; error bars denote standard deviation. Asterisks indicate that fold change in expression between control and treated samples is
statistically signiﬁcant (Po0.05). Right panel – Effect of SMAD4 knockdown on SMAD4 and UCP2 protein levels. Cells transfected with control or smart pool SMAD4 siRNA
and protein extracts analyzed 48h later by western blotting. Partial (50%) reduction in SMAD4 protein resulted in enhanced UCP2 levels. Actin, loading control
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Cell Death and DiseaseCa
2þ has a key role in cell and tissue differentiation, and as
mitochondrial ROS and Ca
2þ regulate each other, UCP2
might be involved in [Ca
2þ]m regulation. As detected by
confocal imaging of Rhod-2 AM and MitoFluor Green dyes
within live populations, grade 3 tumor cells displayed
signiﬁcantly reduced [Ca
2þ]m in comparison with grade 1
cells(Figure5a).UCP2inductioninstablytransfectedgrade1
and 2 tumor cell lines signiﬁcantly decreased [Ca
2þ]m
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Cell Death and Disease(Figure 5b). Moreover, [Ca
2þ]m sequestration evaluated in a
time-dependent manner in UCP2-transduced tumor cells
showed that H2O2-induced [Ca
2þ]m sequestration was
abolished in stable transfectants compared with controls
(Figure 5c). These data provide direct evidence that in addi-
tion to neutralizing mitochondrial ROS, UCP2 overexpression
Figure 3 Enhancementof mitochondrialmembranepotential(Dcm)by UCP2isan underlyingfactorforapoptosisinhibitionintumorcells.(a) UCP2inhibitsapoptosisby
blocking CCCP-mediated uncoupling and mitochondrial depolarization. siRNA-transfected grade 3 cell lines 20h after recovery from 250mM CCCP treatment display Annexin
V–FITC staining by FACS analysis. Apoptotic index represents ratio of CCCP-induced apoptosis: baseline apoptosis. Each experiment was carried out in triplicate; asterisks
representsigniﬁcancebetweencontrolandUCP2knockdowncultures(Po0.05).ReductioninUCP2proteinlevelsareshowninthebottompanel.(b)UCP2knockdownreduces
Dcm and enhances apoptosis. Bivariate JC-1 FACS analysis of Dcm and apoptosis in grade 3 (CCdl675) cells, 24h after UCP2 knockdown. The y axis represents Dcm,
calculatedastheratioofJC-1redﬂuorescence:JC-1greenﬂuorescence.Mitochondrialdepolarizationandsubsequentapoptosisinductionareindicatedbydecreasedred:green
ﬂuorescence intensity ratios. Average of triplicate values shown; asterisk represents signiﬁcance (Po0.05) when compared with NS siRNA control. (c) Microscopic analysis of
reduction in Dcm by JC-1 staining of UCP2 siRNA-transfected grade 3 tumor cell lines. Tumor cells in glass-bottomed plates analyzed by live imaging 24h after siRNA
transfection. Cells with depolarized mitochondria exhibit reduced orange/red ﬂuorescence. Bar¼25mm. (d) UCP2-RNA interference promotes both spontaneous and
staurosporine-inducedapoptosisingrade3(CCdl672)tumorcellspropagatedinMatrigelfor6daysaftertransfection.Cleavedcaspase-3-associatedﬂuorescenceincellstreated
with vehicle or 250mM CCCP. Apoptotic cells stained green, nuclei counterstained with propidium iodide (red). Bar¼50mm. Bottom panel – cell counts derived from four  20
microscopic ﬁelds of each treatment combination indicated. Asterisks represent signiﬁcance (Po0.05) when compared with untreated control. Differences between bar 4 versus
bars 2 and 3 are also signiﬁcant (Po0.05). (e) Exogenous UCP2 induction in grade 1 and 2 tumor cell lines protects from CCCP-mediated mitochondrial depolarization.
Topleft–elevat ionofDcmintumorcellsstablytransducedwithexogenousUCP2determinedbybivariateJC-1andFACSanalysis.Bottomleft–neutralizationofCCCP-induced
mitochondrial depolarization in cells shown in top panel. Data represents MFI of JC-1. Average of triplicate data shown; asterisks indicate signiﬁcant differences (Po0.05) when
compared with vector-alone samples. Right panel – representative FACS dot plots of JC-1 Red (y axis): JC-1 Green (x axis) of data summarized in left panels
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Figure 4 UCP2 promotes growth of tumor cells by regulating endogenous ROS. (a) Intrinsic total ROS levels of breast cancer cell lines of varying histological grade
measured as MFI of C400 by FACS analysis. Error bars represent the standard deviation of triplicate samples, and asterisks indicate signiﬁcance (Po0.05) of comparisons
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superoxide production. Bar¼12.5mM. (c) Flow cytometric analysis of UCP2-regulated mitochondrial superoxide production. MitoSOX Red-stained live grade 3 tumor cells
(CCdl54) were analyzed by FACS at 15, 20, 25 and 30min after trypsinization (corresponding to 0, 5, 10 and 15min measurements by time-lapse microscopic analysis).
Signiﬁcant differences in MitoSOX Red MFI were observed between control and UCP2siRNA-transfected cells at 5, 10 and 15min of antimycin A treatment (*Po0.02,
**Po0.001). (d) UCP2 knockdown enhances oxidative stress-induced growth suppression, reversed by antioxidant treatment. Data represents UCP2 siRNA-transfected
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assay. Each experiment was performed in six replicates. Asterisks indicate signiﬁcant differences (Po0.05) in comparison with peroxide alone treatment
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Cell Death and Diseasereduces [Ca
2þ]m overload in breast tumor cells and likely
mediates the crosstalk between ROS and calcium.
As the above-mentioned physiological changes strongly
inﬂuence cell cycle and cell proliferation, we evaluated the
effects of UCP2-KD directly on the propagation of grade 3 cell
lines. A fourfold reduction was observed in cells positive for the
proliferation marker, Ki-67 (Supplementary Figure S5). Although
proliferation rates of grade 1 and 2 cell lines are signiﬁcantly
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Cell Death and Diseaselower than grade 3 cells, stable UCP2 induction led to the
functional ‘transformation’ of grade 2 to grade 3-like cells, as
reﬂectedbyanincreasedS-phasepopulation(Figure5d).Taken
together, our data are a robust and comprehensive demonstra-
tion of aggressive phenotypes conferred on poorly differentiated
tumors by UCP2 overexpression. Equally important are the
observations that such malignant phenotypes are signiﬁcantly
repressed in well and moderately differentiated primary breast
cancer cells, which exhibit intact signaling of pathways that
regulate UCP2 expression. A schematic illustration in Figure 6
summarizes our extensive ﬁndings, portraying for the ﬁrst
time the potential functional role of UCP2 within a contextual
framework of histological grade of primary breast cancer.
Discussion
Establishing histological grade or differentiation status of
solid tumor tissue is an essential component of current
pathological diagnosis, which serves to deﬁne the magnitude
of risk associated with malignancy. However, the biological
underpinnings of this subjective basis for disease sub-
classiﬁcation remain poorly understood. Here, we show
that UCP2 expression is distinctive between low and high
histological-grade tumors. Moreover, we show that charac-
teristic patterns of UCP2 expression in primary breast tumor
tissue continue to be maintained even in immortalized cell
lines of varying histological grade. At a functional level,
we show that hallmarks of cancer, such as inhibition of cell
differentiation and evasion of cell death in high-grade breast
cancer cells, are mediated through the aberrant expression
of UCP2, a mitochondrial protein. As mitochondria are
a major hub for ROS production, as well as central to cellular
life-death decisions (reviewed in Kroemer
20), their involve-
ment in tumor progression is imperative. Our comprehensive
analysis, focused on mitochondrial function in the context
of histological grade of primary breast cancer, has revealed
that both endogenous and experimentally induced UCP2
serve to reduce [Ca
2þ]m and ROS levels while maintaining
mitochondrial membrane potential (Dcm). Thus, alleviation
of oxidative stress resulting from the higher metabolic
rate, characteristic of rapidly proliferating high-grade tumor
cells, seems to be an adaptation facilitated by UCP2
overexpression.
Assisted through the development and application of novel
breast cancer model systems, our data show that UCP2
overexpression facilitates obliteration of cell differentiation
signals, particularly those imparted through the TGFb
epithelial differentiation master switch. On the basis of these
observations, it could be surmised that as TGFb is a growth-
inhibitory, pro-apoptotic peptide, executionof its effects would
be incompatible with the simultaneous overexpression of
antiapoptoticmolecules,suchasUCP2,withinthesamecells.
In TGFb-responsive breast epithelial cells, induction of TGFb
receptors by their cognate ligand directly activates SMAD
proteins including SMAD1, SMAD2, SMAD3, SMAD5 and
SMAD8, which in turn form transcriptional complexes to
regulate TGFb target genes. In the capacity of a co-SMAD,
SMAD4 has a pivotal role in mediating the anti-mitogenic and
pro-apoptoticeffectsofTGFb(reviewedinMassague ´ etal.
21).
Consistent with this function, SMAD4 expression is often
lower in breast cancer than in the surrounding nonmalignant
epithelium.
22OurdataunderscoresthesigniﬁcanceofRSBEs
within the UCP2 promoter by (1) a demonstration of RSMAD
binding within this region and (2) the induction of UCP2
Figure 5 UCP2 promotes proliferation of tumor cells by regulating [Ca
2þ]m (mitochondrial calcium). (a) Live cell confocal images showing steady state mitochondrial
Ca
2þ levels in breast cancer lines of varying histological grade determined by dual staining with the [Ca
2þ]m probe, Rhod-2 AM (red), and the mitochondrial dye, MitoFluor
Green (green). Bar¼12.5mm (upper panel) and 25mm (lower panel). Mitochondria displayed as green punctate stain. Mitochondrial calcium imaged as red punctate stain.
(b) UCP2 induction results in a striking decline in [Ca
2þ]m retention within grade 1 and 2 tumor cell lines. Top panel – [Ca
2þ]m detected as described in panel c.
Bar¼25mm. Bottom panel – UCP2 induction in tumor cells conﬁrmed by western blot. Tubulin, protein-loading control. (c) Time-lapse video microscopy of UCP2-induced
inhibition of [Ca
2þ]m overload. Top panel – quantitative data acquired in real-time in vector versus UCP2 stably transduced grade 1 tumor cells (CCdl68). Bottom panel –
microscopic images exemplifying real-time changes in Rhod-2 AM ﬂuorescence within a single representative cell with (lower series) and without (upper series) UCP2
transductionatprogressivelyincreasingtimepointsbetween0and1h.(d)UCP2overexpressionenhancesproliferation.Comparisonofcellcycleproﬁlesofvector-transfected
versus exogenous UCP2-induced grade 2 cells with grade 3 cells. Cells were pulse labeled with BrdU to visualize DNA replicating fraction by FACS analysis. Representative
data in pie charts show increased percentage of S-phase cells after UCP2 induction. Baseline cell cycle distribution of moderately and poorly differentiated tumor cells is
distinctly unique reﬂecting their proliferation patterns. UCP2 transduction of grade 2 cells induces a striking resemblance to the proliferation pattern of grade 3 cells. Each
experiment was run in triplicate. Difference in percentage of S-phase cells was signiﬁcant (Po0.05) between grade 1 and grade 3, and also between control versus UCP2-
transduced grade 2
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Figure 6 Schematic representation of UCP2-mediated inhibition of tumor
cell death and differentiation. Loss of TGFb signaling in histological grade 3
breast tumor cells promotes constitutive expression of UCP2, which facilitates
maintenance of DCm and restricts [Ca
2þ]m accumulation leading to reduced
mitochondrial ROS production, thereby augmenting tumor cell survival and
proliferation.Conversely,ingrade1tumorsundermicroenvironmentalstress,UCP2
transcriptional repression is maintained through SMAD-mediated TGFb signaling,
which forces [Ca
2þ]m overload and higher ROS levels, culminating in
differentiation cues and/or cell death
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Cell Death and Diseaseexpression in TGFb-responsive SMAD4-KD cells. Taken
together, the application of primary breast cancer cell lines
of varying histological grade in this study have led to novel
ﬁndings indicative of UCP2 as a TGFb target gene, whereby
(1) UCP2 repression is characteristic of primary nonmalignant
epithelial cell cultures and of grade 1 and 2 tumor cells, and
conversely (2) UCP2 derepression concomitant with TGFb
resistance occurs in grade 3 tumor cells.
Evidence suggests that a major function of UCP2 is to
attenuatemitochondrialproductionoffreeradicalsandprotect
against oxidative damage. As suggested by some reports, an
underlying mechanism in this regard is that UCP2-mediated
uncouplingreducestheproton-motiveforceandDcm,leading
to ROS reduction at the expense of oxidative phosphoryla-
tion.
2,3,8 Our observations in spontaneously overexpressing
grade 3 tumor cells, as well as in experimentally induced
variants of lower histological grade, support a positive
association between UCP2 and Dcm, the implication being
thatrather than functioning asan uncoupler, UCP2 is involved
in the maintenance of Dcm. Our observations are consistent
with the well-known fact that a decline in Dcm is a prelude
to cell death,
11 and would thus be uncharacteristic of aggres-
sive UCP2 overexpressing tumor cells. A similar association
between UCP2 and Dcm was observed in cardiomyocytes
9
and cortical neurons
10 exposed to oxidative stress. An
enhanced Dcm displayed by cancer cell lines, in comparison
with noncancerous cells,
11 suggests a direct relationship
between this phenotype and malignancy. This ﬁnding is in
close agreement with earlier microscopic observations of
the preferential retention of cationic lipophilic drugs within
mitochondria of cancer cell lines and tumor cells in fresh
surgical breast cancer specimens.
23,24
It would also seem that in live tumor cells, wherein ATP is
being continually synthesized, mitochondria are already in a
non-maximum state of membrane potential. Thus, a further
drop in Dcm to alleviate ROS is deemed unnecessary.
20 If
UCP2 does not operate by uncoupling, as shown by its
positive correlation with Dcm, how does it diminish ROS?
Two scenarios could be discussed. As we have shown,
one possibility is that it regulates the entry of Ca
2þ into the
mitochondria, which is known to enhance ROS generation,
and trigger the opening of the mitochondrial permeability
transition pore, thereby leading to apoptosis.
25–27 Consistent
with the role of Ca
2þ in ROS generation are the observations
that[Ca
2þ]muptakeisDcmdependent
28andcontrolsenergy
production.
29 Theoretically, stimulation of the tricarboxylic
acid cycle and oxidative phosphorylation by Ca
2þ consumes
more O2, resulting in greater respiratory chain electron
leakage (or ROS). UCP2-induced inhibition of mitochondrial
Ca
2þ overload and membrane depolarization is suggested
by some,
30 whereas others have proposed that UCP2 is
essential for [Ca
2þ]m uptake.
31 As shown here, UCP2
function in breast cancer cells is reminiscent of the anti-
apoptotic proteins, MCL1 and BCL2 known to prevent
mitochondrial dysfunctionand cell death,elicited bysustained
high levels of intracellular calcium.
32,33 In another scenario,
the proglycolytic phenotype of cancer cells could explain
UCP2-mediated ROS alleviation. One view is that micro-
environmental activation of UCPs may promote the Warburg
effect
34 in cancerous cell populations.
35 Thus, ROS reduction
inhigh-gradetumorcellscouldbeareﬂectionofthismetabolic
shift rooted in the functional mitochondrial plasticity that
enhances glycolysis and permits suppression of oxidative
phosphorylation. Overall, our comprehensive data unequi-
vocally show the relationship between Ca
2þ homeostasis
and mitochondrial bioenergetics in aggressive tumor cells
mediated at least partly through UCP2 overexpression.
The UCP2 activation contributes to the overall molecular
basis for reprogramming of cancer cell metabolism. As many
glycolytic enzymes also regulate apoptosis, and function as
oncoproteins,
36 it seems likely that the glycolytic pheno-
type confers apoptotic resistance
37 and thereby a survival
advantage.
38Conversely,normalizationofDcm,couldleadto
increased apoptosis and reduced cell growth.
11 Although
cancer aggressiveness associated with Dcm enhancement
hasbeenpreviouslyshown,
39toourknowledge,thisistheﬁrst
experimental evidence for UCP2 participation in increasing
mitochondrial membrane potential, decreasing mitochondrial
Ca
2þ overload, neutralizing oxidative stress and thereby
enhancing tumor cell survival, speciﬁcally in primary tumor
cells conferring poor prognosis.
Aberrant upregulation of genes commonly occurs in cancer
cells, often correlated with clinical outcome, but rarely
indicative of a direct role in tumor histopathology. Our unique
approach of interrogating well-characterized surrogate in vitro
models of clinical disease is a means of circumventing
the impasse encountered by the dearth of animal models
to recapitulate the biology underlying histological grade in
human breast cancer. Grade-associated expression of UCP2
portrays a consistent phenotype, and a common biology
between breast cancer cells in the patient host and in
laboratory dishes. Functionally illustrated through pleiotropic
effects ranging from metabolic reprogramming and neutrali-
zation of microenvironmental oxidative stress to circum-
venting apoptotic and differentiation signaling due to its
overexpression in the mitochondria of high-grade breast
cancer cells, UCP2 could serve as a particularly promising
tumor target from the perspective of speciﬁcity and sensitivity.
Materials and Methods
Primary breast carcinoma cell culture. The development of sponta-
neously immortalized high-grade and nonspontaneously immortalized, hTERT-
transduced low and intermediate-grade primary breast cancer cell lines has been
previously described.
17 Primary tumor cell lines were routinely propagated in
previously optimized low calcium MCDB170 medium supplemented with 2% fetal
bovine serum.
40 Treatments included exposure to 4ng/ml TGFb1 (R&D Systems,
Minneapolis, MN, USA).
Immunolocalization. Tissue arrays comprised of formalin-ﬁxed primary
breast cancer samples obtained from the Department of Pathology, California
Paciﬁc Medical Center under IRB-approved guidelines, were deparafﬁnized and
used for immunoperoxidase localization of a goat anti-human UCP2 antibody
(cat. no. C20, Santa Cruz Biotechnology, Santa Cruz, CA, USA) according to the
supplier-recommended protocol, and counterstained with nuclear fast red. Cores
displaying strong cytoplasmic staining with anti-UCP2 in 430% tumor cells were
scored as positive.
For immunocytochemistry, paraformaldehyde-ﬁxed primarytumor cell lineswere
permeablized with Triton X-100, incubated with anti-UCP2 followed by Alexa Fluor
488 anti-goat antibody (Invitrogen), counterstained with propidium iodide (PI) and
analyzed by confocal microscopy. Images from all cell lines were acquired at a
constant voltage gain setting of the detector channel used. Data acquisition for no
antibody control, and anti-UCP2-stained samples was performed under identical
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Cell Death and Diseaseconditions in triplicate. For western blotting, whole cell or mitochondrial lysates
prepared by a mitochondria isolation kit (Thermo Fisher Scientiﬁc, Rockford, IL,
USA) were resolved by SDS–polyacrylamide gel electrophoresis in 12% gels,
transferred to polyvinylidene ﬂuoride membranes and probed with rabbit antibodies
directed at UCP2 (Alpha Diagnostic, San Antonio, TX, USA), SMAD4 (Upstate
Biotechnology, Lake Placid, NY, USA) and ACTB (BioRad, Hercules, CA, USA) or
at mouse anti-TUBA (Abcam, Cambridge, MA, USA) followed by horseradish
peroxidase-tagged secondary antibody (Sigma Aldrich, St. Louis, MO, USA) and
chemiluminescent detection.
For mitochondrial UCP2 localization by confocal microscopy, tumor cells were
dual stained with anti-UCP2 and MitoTracker Red CM-H2XRos (Invitrogen).
Quantitative real-time PCR. RNA isolated with the RNeasy kit (Qiagen,
Valencia, CA, USA) was used to synthesize cDNA for relative gene expression
analysis. UCP2 sequence-speciﬁc FAM probes (Applied Biosystems, Foster City,
CA, USA) and primers (SYBR Green analysis) were used in independent QPCR
assays. ACTB control was included in each PCR reaction. Relative expression of
UCP2 in tumor cell lines was normalized against mean DCt values of short-term
nonmalignant breast epithelial cultures (n¼3). Relative expression of target genes
was calculated as previously described.
17
Cell polarity. Tumor cells in six-well plates were transfected with NS siRNA or
UCP2 siRNA and propagated for 7 days to form colonies from single cells in
Matrigel. Transfection efﬁciency was measured with ﬂuorescent siGLO RISC-free
control siRNA (Thermo Scientiﬁc, Lafayette, CO, USA). Colonies were ﬁxed and
stained with anti-ITGA6 (BD Pharmingen, San Diego, CA, USA), anti-rat secondary
Alexa 633, Alexa Fluor 488 phalloidin (both from Invitrogen) and PI, and examined
by confocal microscopy.
Chromatin immunoprecipitation assay. A ChIP kit (Upstate) was used
in conjunction with tumor cells as per manufacturer’s instructions with minor
modiﬁcations. Cells ﬁxed with 1% paraformaldehyde were sonicated, followed by
immunoprecipitation of DNA–SMAD4 complexes with 5mg anti-SMAD4 antibody
(Upstate).Normal rabbit IgG served as a negative control. After de-crosslinking and
puriﬁcation, DNA was subjected to PCR with AccuPrime Taq DNA polymerase
(Invitrogen) and oligonucleotides for speciﬁc regions in the UCP2 promoter. Input
controls were included in PCR reactions. PCR products were resolved on 2%
agarose gels and visualized by ethidium bromide staining.
Experimental manipulation of UCP2 expression. UCP2 cDNA
(ATCC, Manassas, VA, USA) was subcloned into pcDNA 3.1 using the
directional TOPO Expression System (Invitrogen). In UCP2 induction studies,
primary breast tumor cells were transfected either with UCP2 or empty pcDNA 3.1
vector in the presence of FuGene (Roche, Indianapolis, IN, USA) and harvested for
functional assays.
For UCP2 silencing, tumor cells were transfected with siCONTROL nontargeting
siRNA or a set of four human UCP2-speciﬁc siRNAs (Thermo Scientiﬁc) using
Lipofectamine 2000 (Invitrogen), and evaluated 24h later. TGFb-induced UCP2
silencing was measured by QPCR in cells treated for 24h. In addition, cells
transfected with a set of four human SMAD4-speciﬁc siRNAs (Thermo Scientiﬁc)
were analyzed for UCP2 expression with and without TGFb treatment.
Measurement of Dwm. Tumor cells plated in phenol red-free growth medium
weretreatedwithvehicleor250mMCCCP(SigmaAldrich),followedbyexposureto
vehicle or 1mg/ml JC-1 dye (Invitrogen) for 30min at 371C and analyzed by
FACScan (BD Biosciences, San Jose, CA, USA). Green or red JC-1 ﬂuorescence
signals were resolved by detection in the FL1 and FL2 channels, respectively.
Unstained cells were acquired to set the dot plot quadrants. FACScan
compensation settings were adjusted with CCCP-treated cells. Experiments were
carried out in triplicate and 10000 cells were acquired for each test sample.
Mitochondrial depolarization was measured by a reduction in the red/green
ﬂuorescence intensity ratio. In addition, live cell imaging was performed by confocal
microscopy using red and green ﬂuorescence ﬁlters.
Analysis ofROS. BasalendogenousROSaccrualwas measuredinlivetumor
cell cultures loaded with the ﬂuorogenic dye, Carboxy-H2DCFDA (5-(and-6)-
carboxy-2070-dichlorodihydroﬂuorescein diacetate), also called C-400 (Invitrogen) in
phenol red-free medium for 1h followed by 30min incubation in regular growth
medium. Mitochondrial-speciﬁc superoxide production was measured by dual
labeling of live cells with the ﬂuoroprobes, MitoSOX Red and MitoFluor Green
(Invitrogen) for 30min followed by microscopic imaging. For evaluating the effects
of UCP2 KD on total cellular and mitochondrial ROS levels, siRNA-transfected
cells were labeled with the above-mentioned dyes. In FACS studies, intracellular
oxidationof C-400was measuredin theFL1channel.Oxidationof MitoSOXRed by
superoxide was detected in FL2 and FL3 channels and MitoFluor Green in FL1.
Individual control samples stained with each mitochondrial probe alone were used
for equipment setup. Antimycin A (20mM, Sigma Aldrich) was added to the cells
after ﬁrst microscopic image acquisition or ﬁrst sample acquisition by FACS,
followedbyanalysisatdeﬁnedtimepoints.Experimentswerecarriedoutintriplicate
and 10000 cells were acquired for each sample. ROS activity was expressed as
MFI of the respective dyes.
Measurement of mitochondrial Ca
2þ. Tumor cells plated in glass-
bottomed dishes in phenol red-free growth medium containing 0.1mM Ca
2þ were
treatedfor1hat371Cwithacombinationof5mMRhod-2AMand200nMMitoFluor
Green (Invitrogen). Red and green ﬂuorescence was recorded digitally at constant
voltage gain settings under a  60 oil immersion objective in live cells by confocal
microscopy 24h later. To study the dynamics of Ca
2þ localization in these cells,
Rhod-2AMimageswereacquiredbytime-lapsevideomicroscopyat1minintervals
with a  60 oil immersion objective after H2O2 induction, and analyzed by
NIS-Elementssoftware(Nikon, Tokyo,Japan). Datawere recordedas ﬂuorescence
intensity versus time.
Cell proliferation and apoptosis
Three-dimensional substrate. Relative changes in growth were measured
by colony counts 1 week after plating single tumor cell suspensions in 3% Matrigel
(BD Biosciences). Colonies ﬁxed with 1:1 methanol: acetone, were incubated with
anti-Ki-67(Novocastra,NewcastleuponTyne,UK)followedbyﬂuorescence-tagged
secondary antibody. Proliferating cells represented by green nuclei were visualized
microscopicallyinmultipleﬁeldsandcountedasapercentageofallnuclei.Similarly,
changes in staurosporine-inducedapoptosiswere measured by immunolocalization
of anti-cleaved CASP3 (Cell Signaling, Danvers, MA, USA). Alternately, unﬁxed
cells were stained with ﬂuorescein isothiocyanate (FITC)-tagged anti-annexin V
(BD Biosciences). Apoptotic index was calculated as a ratio of the percentage of
apoptotic cells in untreated versus CCCP-treated tumor cell populations with and
without UCP2 KD.
Two-dimensional substrate. Control or UCP2 siRNA-transfected tumor
cells were incubated with 10mM of 5-bromo-2-deoxyuridine (BrdU) for 24h to
label the proliferating population. BrdU-exposed cells were stained with anti-BrdU
(Santa Cruz Biotechnology) and FITC-conjugated secondary antibody (Invitrogen)
andanalyzedby FACS.Alternately,cellproliferation was measuredby thestandard
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium-bromide; Sigma Aldrich)
assay in a 96-well format, comprised of six replicates for each condition. For cell
cycle distribution, 24h after plating, cells were pulse labeled with 10mM BrdU for
1h and processed as mentioned above.
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